Illumine Investment Management LLC Invests $1.24 Million in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Illumine Investment Management LLC purchased a new position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 13,432 shares of the medical instruments supplier’s stock, valued at approximately $1,238,000. Illumine Investment Management LLC owned about 0.06% of LeMaitre Vascular as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. KBC Group NV lifted its holdings in LeMaitre Vascular by 58.4% during the fourth quarter. KBC Group NV now owns 1,112 shares of the medical instruments supplier’s stock valued at $102,000 after purchasing an additional 410 shares during the last quarter. Empowered Funds LLC purchased a new stake in LeMaitre Vascular during the fourth quarter valued at about $150,000. SG Americas Securities LLC purchased a new stake in LeMaitre Vascular during the fourth quarter valued at about $158,000. Advisors Asset Management Inc. lifted its holdings in LeMaitre Vascular by 180.2% during the third quarter. Advisors Asset Management Inc. now owns 1,852 shares of the medical instruments supplier’s stock valued at $172,000 after purchasing an additional 1,191 shares during the last quarter. Finally, Sanctuary Advisors LLC purchased a new stake in LeMaitre Vascular during the third quarter valued at about $181,000. 84.64% of the stock is owned by hedge funds and other institutional investors.

LeMaitre Vascular Trading Down 3.0 %

Shares of LeMaitre Vascular stock opened at $99.91 on Friday. The firm has a market capitalization of $2.25 billion, a P/E ratio of 54.60, a P/E/G ratio of 2.22 and a beta of 0.96. The business has a fifty day simple moving average of $96.90 and a two-hundred day simple moving average of $94.66. LeMaitre Vascular, Inc. has a 12 month low of $62.39 and a 12 month high of $109.58.

LeMaitre Vascular (NASDAQ:LMAT) last announced its quarterly earnings data on Thursday, February 27th. The medical instruments supplier reported $0.49 EPS for the quarter, meeting the consensus estimate of $0.49. The business had revenue of $55.81 million during the quarter, compared to analyst estimates of $55.99 million. LeMaitre Vascular had a return on equity of 13.15% and a net margin of 19.40%. Analysts predict that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Barrington Research upped their price objective on shares of LeMaitre Vascular from $92.00 to $93.00 and gave the company an “outperform” rating in a report on Friday, November 1st. Oppenheimer restated an “outperform” rating and issued a $93.00 price objective (up from $90.00) on shares of LeMaitre Vascular in a research report on Friday, November 1st. Wells Fargo & Company began coverage on LeMaitre Vascular in a research note on Thursday, February 13th. They set an “equal weight” rating and a $95.00 price objective for the company. Finally, StockNews.com lowered LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Friday, December 13th. Three analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $94.63.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.